G6PD promotes cell proliferation and dexamethasone resistance in multiple myeloma via increasing anti-oxidant production and activating Wnt/β-catenin pathway
Rui Li(The First People's Hospital of Shunde), Chunyan Gu(Nanjing University of Chinese Medicine)
Cited by 24
Related Papers
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
|Molecular Cancer|2021|72
ECHS1, an interacting protein of LASP1, induces sphingolipid-metabolism imbalance to promote colorectal cancer progression by regulating ceramide glycosylation
|Cell Death and Disease|2021|55
A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing
|Journal of Experimental & Clinical Cancer Research|2022|53
Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
|BMC Cancer|2018|37
AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
|Journal of Experimental & Clinical Cancer Research|2022|32